The IIT Roorkee study on Efavirenz offers a new avenue for Chikungunya treatment, bringing optimism to patients and doctors ...

Efavirenz, an HIV drug, shows potential for treating chikungunya virus, inhibiting replication and reducing viral load ...

Roorkee researchers have identified a new potential treatment for Chinkungunya, indicate that Efavirenz, a widely used HIV ...

IIT Roorkee researchers have discovered that Efavirenz, an HIV drug, may help treat Chikungunya by reducing virus replication in lab tests and mice models. While promising, clinical trials are needed ...

The study conducted by IIT Roorkee is supported by the Indian Council of Medical Research (ICMR). It has been published in a ...

Department of Biosciences and Bioengineering, Indian Institute of Technology, Roorkee, Uttarakhand 247667, India ...

Symfi and Symfi Lo are made up of the same generic medications, but Symfi Lo contains a smaller dose of efavirenz. These drugs may cause side effects for the first several weeks. If the side ...

The global HIV drugs industry was valued at USD 28.6 billion in 2023 and is projected to grow at a CAGR of 4.7% from 2024 to ...

HIV-positive mothers with undetectable viral load can now safely breastfeed their infants, according to recently updated ...

Brand Name Generic Name Typical Adult Dosage Dietary Notes Edurant rilpivirine One 25mg tablet 1x/daily Taken with a meal Intelence etravirine One 200mg tablet 2x/day Taken with a meal Pifeltro ...